FDA Authorizes New Long-Acting, Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
The Race Is On: Clinical Trials Begin for Agents Biosimilar to Denosumab
Osteoarthritis Treatments: Monoclonal Antibody Starts Clinical Trial & Fasinumab Promising for Treating Pain
Mucosal Healing Seen with Infliximab Biosimilar CT-P13 in Ulcerative Colitis
Sifalimumab Shows Some Promise Against Lupus
Etanercept Submitted to FDA for Approval to Treat Pediatric Plaque Psoriasis; Boehringer Ingelheim & AbbVie to Collaborate; Low Doses of Gerilimzumab Promising for RA